BSECompany Update16 Sept 2026 · 16 Sept 2026, 05:51 pm
Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we hereby inform that the Company has filed two complaints on September 15,2026 against M/s Anugraha Chemicals ("the Firm") and its partners, on account of dishonour of two cheques issued by the firm towards discharge of outstanding dues payable to the Company.
Pharmaids Pharmaceuticals Ltd · 524572
✦ AI SummaryLitigation
Pharmaids Pharmaceuticals Ltd has filed two complaints against M/s Anugraha Chemicals and its partners for dishonour of two cheques worth ₹2,62,50,000, payable to the Company. The Company is seeking recovery of the outstanding amount.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Pharmaids Pharmaceuticals Ltd - 524572 - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Attachments (1)
📄pdf
Download →
fdcdf501-af4d-4255-8ed7-10785490a295.pdf
View document text
Date: 16.09.2026
BSE Limited
Corporate Relations Department
Phiroze Jeejeebhoy Towers, Dalal Street
Mumbai – 400001
Dear Sir/Madam,
Scrip Code: 524572 | Scrip ID: PHARMAID | ISIN: INE117D01018
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of the
Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”), as amended thereof, we hereby inform that the
Company has filed two complaints under Section 223 of the Bharatiya Nagarik Suraksha
Sanhita, 2023 read with Section 138 of the Negotiable Instruments Act, 1881 on September 15,
2026, against M/s Anugraha Chemicals ("the Firm") and its partners, on account of dishonour
of two cheques issued by the firm towards discharge of outstanding dues payable to the
Company.
The details required to be disclosed as provided in Para B of Part A of Schedule III of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular
No HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are set out in
Annexure 1.
Kindly take the same on your record and oblige.
For Pharmaids Pharmaceuticals Limited
Prasanna Subramanya Bhat
(Company Secretary & Compliance Officer)
PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979)
Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA
Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com
Annexure 1
DETAILS WHICH A LISTED ENTITY NEED TO DISCLOSE FOR EVENTS ON
WHICH THE LISTED ENTITY SHALL APPLY MATERIALITY IN TERMS OF
PARA B OF PART A OF SCHEDULE III OF THE LODR REGULATIONS.
Details of the event Information of such event
1. Brief details of litigation
Name(s) of the opposing party 1. M/s Anugraha Chemicals (the “firm”)
2. Mr. Sourabh S. Hadimani (partner)
3. Mrs. Sneha Hadimani (partner)
Court/Tribunal/Agency where litigation Hon’ble Court of the 34th Additional Chief
is filed Judicial Magistrate, Bengaluru
Brief details of dispute/litigation The Company has filed two complaints
under Section 223 of the Bharatiya Nagarik
Suraksha Sanhita, 2023 read with Section
138 of the Negotiable Instruments Act, 1881
on September 15, 2026, against Anugraha
Chemicals and its partners for dishonour of
two cheques (Cheque Nos. 740165 and
740166) issued towards discharge of an
outstanding amount of ₹2,62,50,000/-
(Rupees Two Crore Sixty-Two Lakh Fifty
Thousand only), payable to the Company
pursuant to a Disinvestment Agreement
dated 10.07.2025 (as modified by a
Supplementary Agreement dated
23.01.2026), executed in connection with
the Company's exit from its partnership
interest in Anugraha Chemicals. Both
cheques were dishonoured on 23.07.2026
with the remark "Payment Stopped by the
Drawer," and despite issuance of statutory
demand notices, the outstanding amount
remains unpaid.
2. Expected financial implications, if any, There are no financial implications or
due to compensation, penalty etc liabilities on the Company arising from this
litigation, as the Company is the
Complainant seeking recovery of amounts
due to it.
PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979)
Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA
Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com
3. Quantum of claims, if any The aggregate quantum of claim is
₹2,62,50,000/- (Rupees Two Crore Sixty-
Two Lakh Fifty Thousand only), being the
outstanding amount covered under the two
dishonoured cheques (₹52,50,000/- under
Cheque No. 740165 and ₹2,10,00,000/-
under Cheque No. 740166), exclusive of
any compensation, interest, or costs that
may be awarded by the Court.
PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979)
Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA
Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com